Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Starcloud $250M Series A extensionAugustus $180M Series BRecent funding activity in US startups, organised by investor and their role in each round.
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Starcloud $250M Series A extensionAugustus $180M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Twin1 AI $20M SeedFlagler Health $50M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 2
Castelion $1B Series CNeros Technologies $250M Series CNew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
XBE Undisclosed GrowthHorizon3 $250M Series ENew companies 2 · Follow-on 0
Stages: Series C+ 2
Abcuro $66M Series DEpicrispr Biotechnologies $90M Series CNew companies 2 · Follow-on 0
Stages: Series C+ 2
Abcuro $66M Series DEpicrispr Biotechnologies $90M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Wispr Flow $280M Series BNatural $30M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Wispr Flow $280M Series BLumilens >$700M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Khartis Therapeutics $50M Series BInfinimmune $75M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Databricks $5B GrowthCandid Health $120M Series DNew companies 1 · Follow-on 1
Stages: Seed 1, Series B 1
Heaviside Industries $60M Series BSoctera $4M SeedNew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Thrive Holdings >$2B GrowthBase Power $1B Series DNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
CodeRabbit $143M Series CUniti $12M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Natural $30M Series AAmbrook $30M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Epicrispr Biotechnologies $90M Series CCrystalys Therapeutics $130M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Discovered Materials $9M SeedMitti Labs $9.5M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Flagler Health $50M Series BThrone Science $10M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Yellow Card $40M StrategicDigital Asset Undisclosed Growth“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.